| CXSL2300015 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-06 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
| JYSB2000688 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB1900197 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-08-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2019-08-06 | view |
| JYSZ2300015 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2200167 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2022-08-30 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2000080 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-03-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-06-10 | view |
| JYSB2500073 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2025-03-20 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2101179 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-11-29 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2000411 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Filed | 2020-09-02 | view |
| JYSB1900129 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
| JYSB2300045 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2023-03-08 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2000693 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB1900334 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-01-22 | view |
| JYSB2500067 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products(1) | Supplementary Application | 2025-03-18 | | Roche Pharma (Schweiz) AG | | | view |
| JYSB2101059 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JXSS2000014 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2020-05-23 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | In Review | 2021-03-30 | view |
| JYSB1900128 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-06-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2019-10-17 | view |
| JYSZ2300018 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | License Renew | 2023-03-30 | | Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2000694 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | In Review | 2022-01-20 | view |
| JYSB1900333 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2019-12-04 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland);Chugai Pharma Manufacturing Co Ltd | Certificate Issued | 2020-01-22 | view |
